Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by Polyrizon Ltd.
Polyrizon Appoints Dr. Michal Meir as Senior Director of Regulatory and Clinical Affairs
December 19, 2024
From
Polyrizon Ltd.
Via
GlobeNewswire
Tickers
PLRZ
Polyrizon's Moving Forward with Expected 2025 Clinical Trial - Entered Manufacturing Agreement for its PL-14 Allergy Blocker
December 18, 2024
From
Polyrizon Ltd.
Via
GlobeNewswire
Tickers
PLRZ
Polyrizon Announces Appointment of VP of Regulatory Affairs and Quality Assurance
December 13, 2024
From
Polyrizon Ltd.
Via
GlobeNewswire
Tickers
PLRZ
Polyrizon Enters into GMP Manufacturing Agreement for CTM Supply of its PL-14 Allergy Blocker in Preparation for Planned 2025 Clinical Trial
December 02, 2024
From
Polyrizon Ltd.
Via
GlobeNewswire
Tickers
PLRZ
Polyrizon Announces Pricing of $4.2 Million Initial Public Offering and Listing on the Nasdaq Capital Market Under New Ticker “PLRZ”
October 28, 2024
From
Polyrizon Ltd.
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.